- Home
- HTHT vs VTAK Comparison
HTHT vs VTAK Comparison
Compare HTHT & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTHT
- VTAK
- Stock Information
- Founded
- HTHT 2005
- VTAK 2002
- Country
- HTHT China
- VTAK United States
- Employees
- HTHT N/A
- VTAK N/A
- Industry
- HTHT Hotels/Resorts
- VTAK Medical/Dental Instruments
- Sector
- HTHT Consumer Discretionary
- VTAK Health Care
- Exchange
- HTHT Nasdaq
- VTAK Nasdaq
- Market Cap
- HTHT N/A
- VTAK 1.1M
- IPO Year
- HTHT 2010
- VTAK 2018
- Fundamental
- Price
- HTHT $40.71
- VTAK $0.37
- Analyst Decision
- HTHT Strong Buy
- VTAK
- Analyst Count
- HTHT 4
- VTAK 0
- Target Price
- HTHT $48.00
- VTAK N/A
- AVG Volume (30 Days)
- HTHT 2.6M
- VTAK 236.7K
- Earning Date
- HTHT 11-22-2024
- VTAK 08-14-2024
- Dividend Yield
- HTHT 3.79%
- VTAK N/A
- EPS Growth
- HTHT 219.13
- VTAK N/A
- EPS
- HTHT 1.62
- VTAK N/A
- Revenue
- HTHT $3,206,043,837.00
- VTAK $436,000.00
- Revenue This Year
- HTHT $11.10
- VTAK $637.10
- Revenue Next Year
- HTHT $8.49
- VTAK $177.13
- P/E Ratio
- HTHT $24.90
- VTAK N/A
- Revenue Growth
- HTHT 30.82
- VTAK 140.88
- 52 Week Low
- HTHT $27.03
- VTAK $0.31
- 52 Week High
- HTHT $42.98
- VTAK $8.40
- Technical
- Relative Strength Index (RSI)
- HTHT 70.69
- VTAK 29.67
- Support Level
- HTHT $38.69
- VTAK $0.35
- Resistance Level
- HTHT $41.57
- VTAK $0.54
- Average True Range (ATR)
- HTHT 1.78
- VTAK 0.05
- MACD
- HTHT 0.36
- VTAK 0.05
- Stochastic Oscillator
- HTHT 81.14
- VTAK 21.57
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.